Another new drug for type 2 diabetes, called Prandin (repaglinide)

    You'll soon see another new drug for type 2 diabetes, called Prandin (repaglinide).

    It's the first of a new class...the meglitinides.

    Prandin is given before meals to reduce postprandial hyperglycemia. It stimulates the pancreas to release more insulin.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote